Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 11.58% is 11% below its 5-year average of 12.99%, near the high end of its 5-year range (0.41%–15.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.93% below its 12-month average of 12.58%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.58%.
DEBT TO ASSETS RATIO
11.58%
DEBT TO ASSETS RATIO AVG TTM
12.58%
DEBT TO ASSETS RATIO AVG 3Y
13.62%
DEBT TO ASSETS RATIO AVG 5Y
12.99%
DEBT TO ASSETS RATIO AVG 10Y
6.80%
DEBT TO ASSETS RATIO AVG 15Y
5.38%
DEBT TO ASSETS RATIO AVG 20Y
8.21%
CURRENT VS TTM AVG
-7.93%
CURRENT VS 3Y AVG
-14.96%
CURRENT VS 5Y AVG
-10.82%
CURRENT VS 10Y AVG
+70.29%
CURRENT VS 15Y AVG
+115.09%
CURRENT VS 20Y AVG
+41.08%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
+11480.10%
vs the sector median at left
KORU Medical Systems, Inc.
Market Cap
$140.05M
Debt to Assets Ratio
11.58%
TTM Avg
12.58%
3Y Avg
13.62%
5Y Avg
12.99%
Market Cap
$138.47M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.77M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$144.48M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$145.54M
Debt to Assets Ratio
0.27%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $140.05M | 11.58% | 12.58% | 13.62% | 12.99% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $138.47M | 0.36% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $137.77M | 0.20% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $142.72M | 0.10% | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $144.48M | 0.02% | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.69M | 0.10% | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $145.54M | 0.27% | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $134.35M | N/A | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $146.30M | 0.00% | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.64M | 0.00% | N/A | N/A | N/A |
Debt/Assets
11.6%
Debt/Equity
0.18
Current Ratio
2.72
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 11.58% |
| 2026-03-31 | 11.77% |
| 2025-12-31 | 12.40% |
| 2025-09-30 | 13.55% |
| 2025-06-30 | 13.59% |
| 2025-03-31 | 13.71% |
| 2024-12-31 | 14.66% |
| 2024-09-30 | 15.50% |
| 2024-06-30 | 14.53% |
| 2024-03-31 | 15.17% |
| 2023-12-31 | 15.62% |
| 2023-09-30 | 13.09% |
| 2023-06-30 | 11.87% |
| 2023-03-31 | 12.03% |
| 2022-12-31 | 11.63% |
| 2022-09-30 | 11.86% |
| 2022-06-30 | 10.69% |
| 2022-03-31 | 10.51% |
| 2021-12-31 | 1.46% |
| 2021-09-30 | 1.95% |
| 2021-06-30 | 0.41% |
| 2021-03-31 | 0.48% |
| 2020-12-31 | 0.60% |
| 2020-09-30 | 0.61% |
| 2020-06-30 | 7.99% |
| 2020-03-31 | 11.12% |
| 2019-12-31 | 2.75% |
| 2019-09-30 | 2.99% |
| 2019-06-30 | 3.78% |
| 2019-03-31 | 4.13% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 0.00% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 7.86% |
| 2012-11-30 | 0.04% |
| 2012-08-31 | 0.05% |
| 2012-05-31 | 9.83% |
| 2012-02-29 | 10.05% |
| 2011-11-30 | 11.08% |
| 2011-08-31 | 12.12% |
| 2011-05-31 | 13.75% |
| 2011-02-28 | 0.16% |
| 2010-11-30 | 17.30% |
| 2010-08-31 | 18.68% |
| 2010-05-31 | 21.70% |
| 2010-02-28 | 23.09% |
| 2009-11-30 | 29.30% |
| 2009-08-31 | 30.52% |
| 2009-05-31 | 35.58% |
| 2009-02-28 | 34.84% |
| 2008-11-30 | 34.84% |
| 2008-08-31 | 56.63% |
| 2008-05-31 | 61.66% |
| 2008-02-29 | 64.79% |
| 2007-11-30 | 79.92% |
| 2007-08-31 | 80.99% |
| 2007-05-31 | 88.75% |
| 2007-02-28 | 81.42% |
| 2006-11-30 | 91.73% |
| 2006-08-31 | 91.37% |
| 2006-05-31 | 94.85% |
| 2006-02-28 | 81.29% |
| 2005-11-30 | 80.12% |
| 2005-08-31 | 83.20% |
| 2005-05-31 | 83.25% |
| 2005-02-28 | 69.88% |
| 2004-11-30 | 67.56% |
| 2004-08-31 | 61.04% |
| 2004-05-31 | 56.17% |
| 2004-02-29 | 50.46% |
| 2003-11-30 | 38.91% |
| 2003-08-31 | 34.42% |
| 2003-05-31 | 36.82% |
| 2003-02-28 | 32.02% |
| 2002-11-30 | 25.44% |
| 2002-08-31 | 25.28% |
